Skip to main content
. 2023 Sep 19;67(10):e00482-23. doi: 10.1128/aac.00482-23

TABLE 3.

Target inhibition by tricyclic NBTIs

Compound S. aureus DNA gyrase IC50 (nM) a S. aureus TopoIV IC50 (nM) b
1a 150 653
1b 229 755
2a c 1,600 1,300 (n = 5)
2b c 4,200 1,400
Gepotidacin (racemic) c 170 2,800
Ciprofloxacin c 28,000 8,600
a

DNA gyrase supercoiling inhibition assay; n = 2.

b

TopoIV decatenation inhibition assay; n = 2 unless otherwise noted in parentheses.

c

Values for amine analogs, gepotidacin, and ciprofloxacin were previously reported (21).